The EMBO Journal

19.1k papers and 2.4M indexed citations i.

About

The 19.1k papers published in The EMBO Journal in the last decades have received a total of 2.4M indexed citations. Papers published in The EMBO Journal usually cover Molecular Biology (15.0k papers), Cell Biology (3.1k papers) and Genetics (3.0k papers) specifically the topics of RNA and protein synthesis mechanisms (2.6k papers), RNA Research and Splicing (1.8k papers) and RNA modifications and cancer (1.7k papers). The most active scholars publishing in The EMBO Journal are Yukihiro Kabeya, Michael W. Bevan, Tony A. Kavanagh, Richard Jefferson, Patrick A. Baeuerle, Carsten Scaffidi, Pierre Chambon, Hugh R.B. Pelham, Joan Massagué and Masao Saitoh.

In The Last Decade

Fields of papers published in The EMBO Journal

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in The EMBO Journal. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in The EMBO Journal

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in The EMBO Journal. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in The EMBO Journal with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025